Muutke küpsiste eelistusi

E-raamat: Reconstructive Transplantation and Regenerative Medicine: The Emerging Interface [Taylor & Francis e-raamat]

Edited by (Wake Forest Institute for Regenerative Medicine), Edited by , Edited by (Wake Forest Institute for Regenerative Medicine)
  • Formaat: 224 pages, 1 Tables, color; 7 Tables, black and white; 17 Line drawings, color; 1 Line drawings, black and white; 11 Halftones, color; 1 Halftones, black and white; 28 Illustrations, color; 2 Illustrations, black and white
  • Sari: Gene and Cell Therapy
  • Ilmumisaeg: 12-Nov-2021
  • Kirjastus: CRC Press
  • ISBN-13: 9780429260179
  • Taylor & Francis e-raamat
  • Hind: 180,03 €*
  • * hind, mis tagab piiramatu üheaegsete kasutajate arvuga ligipääsu piiramatuks ajaks
  • Tavahind: 257,19 €
  • Säästad 30%
  • Formaat: 224 pages, 1 Tables, color; 7 Tables, black and white; 17 Line drawings, color; 1 Line drawings, black and white; 11 Halftones, color; 1 Halftones, black and white; 28 Illustrations, color; 2 Illustrations, black and white
  • Sari: Gene and Cell Therapy
  • Ilmumisaeg: 12-Nov-2021
  • Kirjastus: CRC Press
  • ISBN-13: 9780429260179

This book summarizes rapid progress and innovation in transplantation and regenerative medicine - the merger of reconstructive plastic surgery and transplantation - called Vascularized Composite Allotransplantation. This merger includes a wide variety of previously impossible translplantations using grafts derived from organ donors.



This book summarizes rapid progress and innovation in transplantation and regenerative medicine - the merger of reconstructive plastic surgery and transplantation - called Vascularized Composite Allotransplantation. This merger includes face, hand, uteri, larynx, tongue, penis and trachea translplantations as well as other body part transplants using grafts derived from organ donors. These sorts of transplants are now performed more commonly. Cell therapies for immunomodulation are surrogates for immune responses after transplantation to non-invasive imaging of neuroregeneration for improving functional outcomes after transplant.

Contributors vii
SECTION I Cellular Therapies in Reconstructive Transplantation
Chapter 1 Cell Therapies in Reconstructive Transplantation
3(24)
Curtis L. Cetrulo Jr.
Amalya S. Wilson
Abraham Malar
Radbeh Torabi
Mohammadreza S. Pakyari
Elise Lupon
Marion Goutard
Alexandre G. Lellouch
Chapter 2 Novel T-Regulatory Cell-Based Therapies in Vascularized Composite Allotransplantation: Translational Implications
27(20)
Yalcin Kulahci
Hulya Kapucu
James D. Fisher
Steven R. Little
SECTION II Unique Considerations and Emerging Indications in Reconstructive Transplantation
Chapter 3 Invasive and Non-Invasive Surrogates for Chronic Rejection in Vascularized Composite Allotransplantation: Claims and Controversies
47(14)
Nicholas L. Robbins
Warren C. Breidenbach
Chapter 4 Reperfusion Injury in Vascularized Composite Tissue Allografts: Impact on Graft Outcomes and Preventive Strategies
61(14)
Kagan Ozer
Chapter 5 Pediatric Upper Extremity Vascularized Composite Allotransplantation: Progress and Insights
75(26)
Kevin J. Zuo
Anna Gold
Randi Zlotnik Shaul
Emily S. Ho
Gregory H. Borschel
Ronald M. Zuker
SECTION III Graft Monitoring in Reconstructive Transplantation
Chapter 6 Targeted Imaging and Therapeutic Technologies in Neuroregeneration
101(20)
Jelena M. Janjic
Mindly Balogh
Sandeep Kumar Reddy Adena
Amanda Fitzpatrick
John A. Pollock
Vijay Gorantla
Andrew J. Shepherd
Chapter 7 Biomarkers and Surrogates of Acute Rejection in Vascularized Composite Allograft Transplantation
121(28)
Calum Honeyman
Helen Stark
Hayson Chenyu Wang
Joanna Hester
Henk Giele
Fadi Issa
SECTION IV Composite Tissue Graft Manipulation and Engineering
Chapter 8 Bioengineering Composite Tissue Constructs: Concepts and Challenges
149(22)
Kavit Amin
David Leonard
Li Yenn Yong
Ralph Murphy
Roxana Moscalu
Kirsten Liggat
Jason Wong
Chapter 9 Advances in Biomaterials for Reconstructive Transplantation
171(24)
Ashish Dhayani
Praveen Kumar Vemula
Chapter 10 Gene Editing Strategies for Immunomodulation: Translation from Cells to Vascularized Tissues
195(12)
Fatih Zor
Esra Goktas
Vijay Gorantla
Index 207
Dr. Vijay Gorantla, MD, PhD, FRCS, is Professor of Surgery, Ophthalmology and Bioengineering and Director, Vascularized Composite Allotransplantation Program at the Atrium Health Wake Forest Baptist Medical Center, Winston Salem, North Carolina. Dr. Gorantlas widely published expertise involves reconstructive transplantation after civilian or combat trauma with specific focus on graft targeted strategies for immune modulation, extended preservation, or non-invasive surveillance of these complex transplants.

Dr. Fatih Zor, MD, is Assistant Professor of Surgery at the Wake Forest Institute for Regenerative Medicine, Atrium Health Wake Forest Baptist Medical Center, Winston Salem, North Carolina. Dr. Zor was recruited from the Gulhane Military Medical Academy in Turkey and holds a long-published track record with over 140 publications spanning clinical reconstructive surgery, microsurgery, and translational research in reconstructive transplantation.

Dr. Jelena M. Janjic, PhD, is Associate Professor of Pharmaceutics, at the Duquesne University School of Pharmacy, Pittsburgh, Pennsylvania. Dr. Janjic pioneered pain nanomedicine with distinguished expertise in theranostics, nanoimaging and targeted nanodrug delivery in inflammation, nerve regeneration, organ preservation and transplantation. Her research has led to multiple imaging technology patents and highlighted in over 50 publications including special journal issues and book chapters.